• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用定性和定量特征对 CT 上的胰腺神经内分泌肿瘤和胰腺肾细胞癌转移进行区分。

Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.

机构信息

Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada.

Department of Diagnostic Imaging, The Ottawa Hospital- Civic Campus, 1053 Carling Avenue, Ottawa, ON, K1Y 4E9, Canada.

出版信息

Abdom Radiol (NY). 2019 Mar;44(3):992-999. doi: 10.1007/s00261-018-01889-x.

DOI:10.1007/s00261-018-01889-x
PMID:30603880
Abstract

PURPOSE

To assess qualitative and quantitative imaging features on enhanced CT that may differentiate pancreatic neuroendocrine tumors (PNETs) from pancreatic renal cell carcinoma (RCC) metastases.

METHODS

This IRB-approved multi-center retrospective case-control study compared 43 resected PNETs and 28 resected RCC metastases with pre-operative enhanced CT identified consecutively between 2003 and 2017. Two blinded radiologists (R1/R2) independently assessed tumor location, attenuation (relative to pancreas), composition (solid/cystic/mixed), homogeneity (homogeneous/heterogeneous), calcification, multiplicity, and for main pancreatic duct (MPD) dilation. Tumors were segmented for quantitative texture analysis. Data were analyzed with Chi square, logistic regression, and receiver operating characteristic (ROC). Inter-observer agreement was assessed (Cohen's kappa).

RESULTS

There was no difference in age, gender, location, attenuation, or composition (P > 0.05) between groups. PNETs were larger than RCC metastases (37 ± 23 mm vs. 26 ± 21 mm, P = 0.038), more frequently solitary (P < 0.001), subjectively more heterogeneous (P = 0.033/0.144, R1/R2), and associated with calcification (P = 0.002/0.004) and MPD dilation (P = 0.025/0.006). Agreement for subjective features was moderate-to-almost perfect (K = 0.4879-0.9481). Quantitative texture analysis showed higher entropy in PNETs (6.32 ± 0.49 versus 5.96 ± 0.53; P = 0.004) with no difference in other features studied (P > 0.05). Entropy had ROC area under the curve for diagnosis of PNET of 0.77 ± 0.06, with optimal sensitivity/specificity of 71.4/79.1%.

CONCLUSIONS

Compared to pancreatic RCC metastases, PNETs are larger, more frequently solitary, contain calcification, show MPD dilation, and are subjectively and quantitatively more heterogeneous tumors.

摘要

目的

评估增强 CT 的定性和定量成像特征,以区分胰腺神经内分泌肿瘤(PNET)与胰腺肾细胞癌(RCC)转移。

方法

这项经过机构审查委员会批准的多中心回顾性病例对照研究比较了 2003 年至 2017 年间连续切除的 43 例 PNET 和 28 例 RCC 转移瘤,术前均行增强 CT 检查。两名盲法放射科医生(R1/R2)独立评估肿瘤位置、衰减(相对于胰腺)、成分(实性/囊性/混合性)、均匀性(均匀/不均匀)、钙化、多发性和主胰管(MPD)扩张。对肿瘤进行定量纹理分析。采用卡方检验、逻辑回归和受试者工作特征(ROC)分析数据。评估了观察者间的一致性(Cohen's kappa)。

结果

两组间在年龄、性别、位置、衰减或成分方面无差异(P>0.05)。PNET 比 RCC 转移瘤大(37±23mm 比 26±21mm,P=0.038),更常为单发(P<0.001),主观上更不均匀(P=0.033/0.144,R1/R2),与钙化(P=0.002/0.004)和 MPD 扩张(P=0.025/0.006)相关。主观特征的一致性为中至高(K=0.4879-0.9481)。定量纹理分析显示 PNET 中熵值较高(6.32±0.49 比 5.96±0.53;P=0.004),而其他研究特征无差异(P>0.05)。熵值对 PNET 诊断的 ROC 曲线下面积为 0.77±0.06,最佳敏感性/特异性为 71.4/79.1%。

结论

与胰腺 RCC 转移瘤相比,PNET 体积较大,更常为单发,含有钙化,显示 MPD 扩张,且主观和定量上更不均匀。

相似文献

1
Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.使用定性和定量特征对 CT 上的胰腺神经内分泌肿瘤和胰腺肾细胞癌转移进行区分。
Abdom Radiol (NY). 2019 Mar;44(3):992-999. doi: 10.1007/s00261-018-01889-x.
2
Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.胰腺内副脾与胰腺小的富血管神经内分泌肿瘤的鉴别:对比增强计算机断层扫描的纹理分析
Acta Radiol. 2019 May;60(5):553-560. doi: 10.1177/0284185118788895. Epub 2018 Aug 7.
3
MDCT findings of pancreatic metastases according to primary tumors.根据原发肿瘤的胰腺转移瘤的多层螺旋CT表现
Abdom Imaging. 2015 Aug;40(6):1595-607. doi: 10.1007/s00261-014-0299-2.
4
Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.肾细胞癌胰腺转移瘤与富血供神经内分泌肿瘤的鉴别:相对百分比洗脱值的应用及其临床意义。
Eur J Radiol. 2015 Nov;84(11):2089-96. doi: 10.1016/j.ejrad.2015.08.007. Epub 2015 Aug 20.
5
Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.使用增强 CT 鉴别非富血供胰腺神经内分泌肿瘤和肿块型胰腺炎。
Acta Radiol. 2021 Feb;62(2):190-197. doi: 10.1177/0284185120921503. Epub 2020 May 6.
6
Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.胰腺神经内分泌肿瘤与胰腺导管腺癌的鉴别诊断:应用全肿瘤 CT 纹理分析作为定量标志物。
Cancer Med. 2018 Oct;7(10):4924-4931. doi: 10.1002/cam4.1746. Epub 2018 Aug 27.
7
Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.胰腺神经内分泌肿瘤的 CT 增强纹理分析:与 WHO 分级的相关性。
Abdom Radiol (NY). 2019 Feb;44(2):576-585. doi: 10.1007/s00261-018-1763-1.
8
Diagnostic Accuracy of Unenhanced CT Analysis to Differentiate Low-Grade From High-Grade Chromophobe Renal Cell Carcinoma.平扫 CT 分析对低级别与高级嫌色细胞肾细胞癌的鉴别诊断准确性。
AJR Am J Roentgenol. 2018 May;210(5):1079-1087. doi: 10.2214/AJR.17.18874. Epub 2018 Mar 16.
9
Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.基于 CT 特征和纹理分析预测胰腺神经内分泌肿瘤分级。
AJR Am J Roentgenol. 2018 Feb;210(2):341-346. doi: 10.2214/AJR.17.18417. Epub 2017 Nov 15.
10
Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.应用动态增强 CT 对胰腺神经内分泌癌和高分化神经内分泌肿瘤进行比较。
Eur Radiol. 2020 Sep;30(9):4772-4782. doi: 10.1007/s00330-020-06867-w. Epub 2020 Apr 28.

引用本文的文献

1
Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.基于放射组学的人工智能在胰腺导管腺癌中的进展。
Bioengineering (Basel). 2025 Aug 6;12(8):849. doi: 10.3390/bioengineering12080849.
2
Differentiation between renal cell carcinoma metastases to the pancreas and pancreatic neuroendocrine tumors in patients with renal cell carcinoma on CT or MRI.肾细胞癌患者中,通过CT或MRI鉴别肾细胞癌转移至胰腺与胰腺神经内分泌肿瘤。
Abdom Radiol (NY). 2025 Jan 7. doi: 10.1007/s00261-024-04787-7.
3
Surgery for an Uncommon Pathology: Pancreatic Metastases from Renal Cell Carcinoma-Indications, Type of Pancreatectomy, and Outcomes in a Single-Center Experience.
罕见病理的手术治疗:肾细胞癌胰腺转移——单中心经验中的手术指征、胰腺切除术类型及预后
Medicina (Kaunas). 2024 Dec 17;60(12):2074. doi: 10.3390/medicina60122074.
4
Development and validation of A CT-based radiomics nomogram for prediction of synchronous distant metastasis in clear cell renal cell carcinoma.基于CT的影像组学列线图用于预测透明细胞肾细胞癌同步远处转移的开发与验证
Front Oncol. 2023 Jan 4;12:1016583. doi: 10.3389/fonc.2022.1016583. eCollection 2022.
5
Misdiagnosis of pancreatic metastasis from renal cell carcinoma: A case report.肾细胞癌胰腺转移误诊1例报告
World J Clin Cases. 2022 Sep 6;10(25):9012-9019. doi: 10.12998/wjcc.v10.i25.9012.
6
Metastasis from Renal Cell Carcinoma to Ectopic Pancreas Diagnosed after Resection.肾细胞癌转移至异位胰腺,在切除后诊断。
Intern Med. 2023 Apr 1;62(7):1011-1015. doi: 10.2169/internalmedicine.9731-22. Epub 2022 Aug 30.
7
Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma.CT鉴别胰腺实质转移瘤与胰腺导管腺癌的效用
Cancers (Basel). 2021 Jun 22;13(13):3103. doi: 10.3390/cancers13133103.
8
Application of Radiomics Analysis Based on CT Combined With Machine Learning in Diagnostic of Pancreatic Neuroendocrine Tumors Patient's Pathological Grades.基于CT的影像组学分析联合机器学习在胰腺神经内分泌肿瘤患者病理分级诊断中的应用
Front Oncol. 2021 Feb 11;10:521831. doi: 10.3389/fonc.2020.521831. eCollection 2020.
9
CT and MRI of pancreatic tumors: an update in the era of radiomics.胰腺肿瘤的 CT 和 MRI:放射组学时代的新进展。
Jpn J Radiol. 2020 Dec;38(12):1111-1124. doi: 10.1007/s11604-020-01057-6. Epub 2020 Oct 21.
10
When to biopsy Prostate Imaging and Data Reporting System version 2 (PI-RADSv2) assessment category 3 lesions? Use of clinical and imaging variables to predict cancer diagnosis at targeted biopsy.何时对前列腺影像报告和数据系统第2版(PI-RADSv2)评估类别为3类的病变进行活检?利用临床和影像变量预测靶向活检时的癌症诊断。
Can Urol Assoc J. 2021 Apr;15(4):115-121. doi: 10.5489/cuaj.6781.